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Abstract Plasmids for the high-level overproduction of wild-
type, and C- and N-terminal His-tagged MurG N-acetylglucos-
aminyl transferase from Escherichia coli were constructed. In
complementation tests the three forms were active in vivo. After
IPTG induction, growth, spheroplast formation and lysis,
overproduced MurG proteins were mainly present (90%) in the
particulate fraction. Readily solubilized by CHAPS, they were
purified without any detergent to over 80% purity for both His-
tagged forms but only up to 20% for the wild-type form. The
enzymatic activity of each purified MurG protein was determined
and found to be inhibited to the same extent by ramoplanin.
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1. Introduction
The biosynthesis of bacterial cell wall peptidoglycan is a
complex two-stage process. The ¢rst stage concerns the assem-
bly of its monomer unit by enzymes located in the cytoplasm
or at the inner side of the cytoplasmic membrane, whereas the
second stage involves polymerization reactions taking place at
the outer side of the cytoplasmic membrane. This implies the
passage of the monomer unit from the cytoplasm to the ex-
ternally located sites of polymerization through the hydropho-
bic environment of the membrane and is achieved by the for-
mation of lipid intermediates [1^3]. First, a transferase (or
translocase) catalyzes the transfer of the phospho-N-acetyl-
muramoyl-pentapeptide (phospho-MurNAc-pentapeptide)
moiety from the cytoplasmic precursor UDP-MurNAc-penta-
peptide to the membrane acceptor undecaprenyl phosphate to
yield MurNAc-(pentapeptide)-pyrophosphoryl undecaprenol
(lipid I). Thereafter, at least in the simple case of Escherichia
coli, an N-acetylglucosaminyl transferase catalyzes the addi-
tion of N-acetylglucosamine (GlcNAc) to lipid I, yielding
GlcNAc-MurNAc-(pentapeptide)-pyrophosphoryl undecapre-
nol (lipid II) which, after its transfer to the outer side of the
cytoplasmic membrane, is used as the initial substrate for the
polymerization reactions.
The E. coli N-acetylglucosaminyl transferase has been iden-
ti¢ed as the product of the murG gene, which is located in the
dcw cluster at 2 min on the chromosome [4,5] and which has
been cloned and sequenced [6,7]. MurG is an essential cationic
protein of 354 amino acids with a molecular mass of 37 684
Da [4,8]. Moreover, it was shown to be associated with the
inner face of the cytoplasmic membrane [9], thereby establish-
ing that the entire peptidoglycan monomer unit is assembled
before being transferred across the membrane. MurG is thus a
key enzyme at the borderline between the two stages of pep-
tidoglycan synthesis and can be considered as a potential tar-
get for the search of novel antibacterials. In the present paper
we report the overproduction of the wild-type and His-tagged
MurG proteins from E. coli, their solubilization, their puri¢-
cation, and some of their properties.
2. Materials and methods
2.1. Bacterial strains, plasmids and growth conditions
E. coli strains JM83 (F3 ara v[lac-proAB] rpsL thi [x80 dlacv-
(lacZ)M15]), and JM109 (endA1 recA1 thi gyrA96 hsdR17 relA1
supE44 v[lac-proAB], [F3 traD36 lacIq dlacv(lacZ)M15 proAB])
[10] were used as hosts for plasmids and for the preparation of the
overproduced wild-type and mutant MurG transferases. Strain GS58
carrying an amber murG mutation in a thermosensitive supF suppres-
sor background was previously described [8]. Plasmid vectors pQE30,
pQE60, and pREP4 were purchased from Qiagen (Courtaboeuf,
France). 2YT medium [11] was used and growth at 37‡C was moni-
tored by turbidity measurements at 600 nm. For strains carrying drug
resistance genes ampicillin and kanamycin were used at 100 and 30 Wg/
ml, respectively.
2.2. Chemicals and analytical procedures
Lauryldimethylamine oxide (LDAO) was purchased from Calbio-
chem (La Jolla, CA, USA), sodium deoxycholate (DOC) from BDH
(Poole, UK), Ni-NTA agarose from Qiagen (Courtaboeuf, France),
isopropyl-L-D-thiogalactopyranoside (IPTG) from Eurogentec (Sera-
ing, Belgium), and t-octyl-phenoxy-polyethoxyethanol (Triton X-100)
and 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate
(CHAPS) from Sigma (St. Louis, MO). Ramoplanin was a gift
from Lepetit (Milan, Italy). Sodium dodecyl sulfate-polyacrylamide
gel electrophoreses (SDS-PAGE) were performed as previously de-
scribed [4]. Protein content was determined by the method of Brad-
ford [12] using bovine serum albumin as a standard.
2.3. General DNA techniques and E. coli cell transformation
Small- and large-scale plasmid isolations were carried out by the
alkaline lysis method [13]. Standard procedures for endonuclease di-
gestions, ligations, and agarose electrophoresis were used [13,14].
E. coli cells were made competent for transformation with plasmid
DNA by the method of Dagert and Ehrlich [15] or by electroporation.
2.4. Construction of plasmids carrying the murG gene
The murG gene [6,7] was ampli¢ed by PCR from the chromosomal
DNA of E. coli strain JM83 and was cloned into pQE vectors which
are based on the phage T5 transcription-translation system. For ex-
pression of wild-type MurG, primers were 5P-AAGAATTCATTAAA-
GAGGAGAGGTTCACGATGAGTGGTCAAGGAA-3P (primer A),
and 5P-AAGGCAGATCTACAATTACGCCCGGGCAACCCGGC-
TCACTTC-3P (primer B). Primer A contained an EcoRI site (in
bold), followed by a 21 bp sequence including the optimal ribo-
some-binding site found in pQE vectors, and 16 bp of the murG read-
ing frame (initiation codon underlined). Primer B contained a BglII
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site (in bold) and 31 bp of anticoding sequence including the native
stop codon. Ampli¢ed DNA was cut with EcoRI and BglII and in-
serted between the corresponding sites of vector pQE60, generating
plasmid pDMC1. For expression of N-terminal His-tagged MurG,
PCR primers were 5P-CGAGGGGATCCATGAGTGGTCAAGGA-
AAGCGA-3P (primer C), and 5P-ATCGCTGCAGTTACGCCCGGG-
CAACCC-3P (primer D). Primer C contained a BamHI site (in bold),
followed by the ¢rst 21 bp of the murG reading frame. Primer D
contained a PstI site (in bold), and 17 bp of anticoding sequence
including the native stop codon. Ampli¢ed DNA was cut with BamHI
and PstI and inserted into the corresponding sites of vector pQE30,
generating plasmid pDMC2. For expression of C-terminal six His-
tagged MurG, PCR primers were primer A (see above) and
5P-CGCTAAGATCTCGCCCGGGCAACCCGGC-3P (primer E).
Primer E contained a BglII site (in bold), and 17 bp of anticoding
sequence corresponding to the end of the murG gene sequence without
the native stop codon. The ampli¢ed DNA fragment was cut with
EcoRI and BglII, and was inserted between the corresponding sites
of vector pQE60, generating plasmid pDMC3.
2.5. Preparation of crude extracts from MurG overproducing strains
Strains JM109(pDMC1), JM109(pDMC2), and JM109(pDMC3)
were grown under strong aeration at 37‡C. Cultures supplemented
with 1 mM IPTG at OD 0.25 stopped growing after 2 h and cells
were harvested in the cold at OD 0.8 1 h later. Spheroplasts, prepared
as described previously [16], were lysed in 50 mM Tris-HCl, pH 8, and
treated with DNase and RNase. After centrifugation at 200 000Ug for
20 min at 4‡C, the pellet (30 mg protein from 2 g bacteria) was
resuspended in 1 ml of 20 mM potassium phosphate, pH 7, containing
0.1 mM MgCl2 and 1 mM 2-mercaptoethanol (bu¡er A) and stored at
320‡C.
2.6. Solubilization of MurG by salt or detergent treatments
Spheroplast membranes were treated at 4‡C for 15^60 min with
either 0.2 M NaCl, 0.2 M potassium phosphate (pH 7), or 1.5 M
LiCl according to Taku and Fan [17]. Solubilization by detergents
was performed by treatments at 4‡C for 15^60 min with either Triton
X-100 (0.01, 0.1 or 0.5 M), 0.1% DOC, CHAPS (0.5, 1 or 2%) or
2.6 mM LDAO. For preparative purposes spheroplast membranes
(75 mg protein) suspended in bu¡er A (5 ml) containing 0.5% CHAPS
were gently stirred for 1 h at 4‡C. After centrifugation at 200 000Ug
for 20 min at 4‡C the treatment was repeated twice and supernatants
pooled.
2.7. Puri¢cation of solubilized MurG proteins
CHAPS-solubilized material (75 mg protein) from wild-type MurG
overproducing strain JM109(pDMC1) was applied onto a DEAE-Tris-
acryl M (IBF-Pharmindustrie, Villeneuve-la-Garenne, France) col-
umn (1.2U20 cm). Elutions were carried out at 4‡C ¢rst with 30 ml
of 20 mM Tris-HCl, pH 8, and thereafter with a 0^0.6 M NaCl
gradient (90 ml) in the same bu¡er. Eluents were recovered in 1 ml
fractions. CHAPS-solubilized material (25 mg protein) originating
from His-tagged MurG overproducing strain JM109(pDMC2) or
JM109(pDMC3) was gently stirred batchwise overnight at 4‡C with
1 ml of Ni-NTA-agarose. Elutions were carried out on a small column
at 4‡C ¢rst with 50 mM sodium phosphate, pH 8, containing 20 mM
imidazole (4 ml), and thereafter by stepwise increase of the imidazole
concentration up to 400 mM. Puri¢cation was achieved by gel ¢ltra-
tion on a Superose 12 (Pharmacia, Uppsala, Sweden) column (1U30
cm) eluted with 20 mM Tris-HCl, pH 8, at a £ow rate of 0.5 ml/min.
Puri¢cation of the highly overproduced MurG proteins was followed
by SDS-PAGE.
2.8. Enzymatic assay
N-Acetylglucosaminyl transferase activity was assayed as previously
described [4]. The reaction mixture contained, in a ¢nal volume of 25
Wl, 0.1 M Tris-HCl, pH 7.5, 40 mM MgCl2, 30 mM ATP, 0.7 mM
UDP-MurNAc-pentapeptide, 4 WM UDP-[14C]GlcNAc (9.3 GBq/
mmol), E. coli membranes (90 Wg of protein) prepared by sonication
from strain JM109, and MurG protein (10 Wg). All components except
the radiolabeled substrate were ¢rst incubated for 10 min at 35‡C in
order to generate lipid I. The reaction was initiated by the addition of
UDP-[14C]GlcNAc. After 30 min at 35‡C it was stopped by boiling
for 3 min. Reaction mixtures were applied to Whatman 1 ¢lter paper
(length 50 cm) and subjected to descending chromatography for 16 h
in isobutyric acid/1 M ammonium hydroxide (5/3). Radioactivity was
located and counted with a scanner (Tracemaster LB285, Berthold,
Bad Wilbad, Germany). Activities were expressed as nmol of trans-
ferred N-acetylglucosamine per min and per mg of MurG protein.
2.9. Complementation test
The extremely high transcription rate initiated at the T5 promoter
of pQE vectors can only be e⁄ciently repressed by the presence of
high levels of the lac repressor protein. For this reason, the murG Ts
strain GS58 was ¢rst transformed with the low-copy plasmid pREP4
which confers kanamycin resistance and constitutively expresses the
LacI repressor protein. The resulting strain GS58(pREP4) was trans-
formed by the pDMC plasmids to be tested for complementation. In
each case, competent cells were mixed with plasmid DNA and the
suspension was kept on ice for 3 h before being heated for 3 min at
42‡C. After addition of 2YT medium cells were incubated at 30‡C for
at least 2 h and aliquots were plated onto two 2YT plates supple-
mented with ampicillin and kanamycin, one incubated at 30‡C and
the other at 42‡C. Growth was observed after 24 h.
3. Results
3.1. Overproduction of wild-type and His-tagged MurG
proteins
A plasmid suitable for the overproduction of the wild-type
MurG protein, pDMC1, was constructed by cloning the E.
coli murG gene under the control of the strong phage T5
promoter in vector pQE60. In order to discriminate between
chromosomal and plasmid-originating enzymes and to allow
for a rapid one-step puri¢cation procedure, plasmid vectors
that expressed His-tagged forms of MurG were also con-
structed. Plasmids pDMC2 and pDMC3 were similar to
Fig. 1. Overproduction of wild-type and His-tagged MurG proteins
visualized in crude extracts. Cells were grown exponentially at 37‡C
up to OD 0.25 before addition of IPTG (1 mM ¢nal concentration)
to cultures D, F and H. Cells were harvested 3 h later at OD 0.8
and boiled prior to SDS-PAGE. Lane A, JM109; lane B, molecular
mass standards (94 kDa, phosphorylase b; 67 kDa, bovine serum
albumin; 43 kDa, ovalbumin; 30 kDa, carbonic anhydrase); lanes
C and D: strain JM109(pDMC1) without and with IPTG; lanes E
and F: strain JM109(pDMC2) without and with IPTG; lanes G
and H: strain JM109(pDMC3) without and with IPTG. Staining
was performed with Coomassie brilliant blue R250 (Merck, Darm-
stadt, Germany).
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pDMC1 but expressed MurG with a 12-amino acid residue N-
terminal extension (Met-Arg-Gly-Ser-His6-Gly-Ser) and an
8-amino acid residue C-terminal extension (Arg-Ser-His6), re-
spectively. SDS-PAGE analysis of extracts from strains
JM109(pDMC1), JM109(pDMC2) and JM109(pDMC3)
clearly showed (Fig. 1) that IPTG induction led to a high-
level overproduction of a 38-kDa protein corresponding to the
theoretical molecular mass of the murG gene product [4,5]. It
was mainly present (ca. 90%) in the particulate fraction from
spheroplasts. Sonication led to a greater extent of solubiliza-
tion (ca. 50%) but also to signi¢cant losses of enzymatic ac-
tivity (data not shown). Therefore, spheroplast membranes
were preferentially used as starting material for solubilization
and puri¢cation of the MurG proteins.
3.2. Complementation
The di¡erent pDMC plasmids were transformed into the
thermosensitive strain GS58, the only murG mutant charac-
terized to date [8]. Only few transformants were obtained in
each case, due probably to the unregulated and toxic expres-
sion of murG in the absence of IPTG in the strain. Trans-
formation of GS58 by a ¢rst plasmid, pREP4, which expresses
constitutively the lac repressor protein, was thus a prerequisite
for complementation tests of the murG defect. The three
pDMC plasmids restored growth of the mutant strain
GS58(pREP4) at the restrictive temperature, indicating that
the wild-type and His-tagged MurG proteins were active.
3.3. Solubilization and puri¢cation
Di¡erent techniques were examined to solubilize MurG
from spheroplast membranes: salt (LiCl, NaCl, K phosphate)
or detergent (DOC, CHAPS, LDAO, Triton X-100) treat-
ments. CHAPS and LDAO were the most successful in terms
of yield and conservation of enzymatic activity. Although
SDS-PAGE analysis showed that LDAO led to a selective
extraction of MurG on a 1 mg protein scale (data not shown),
extraction with CHAPS was preferred since it led to more
reproducible results on a 10^100 mg protein scale.
The wild-type MurG protein was partially puri¢ed by one-
step DEAE chromatography. It was eluted at about 0.15 M
NaCl and accounted for ca. 20% of the protein content in the
main fraction recovered (Fig. 2). Attempts to further purify
wild-type MurG by other classical column chromatographies
remained unsuccessful. This prompted us to purify the His-
tagged MurG proteins from JM109 (pDMC2) and JM109
(pDMC3) by a⁄nity chromatography on Ni-NTA agarose.
They were recovered in fractions eluting between 100 and
400 mM imidazole. After concentration, ¢nal puri¢cation
and removal of imidazole were achieved by gel ¢ltration. On
SDS-PAGE the His-tagged MurG proteins accounted both
for 80% of the protein contents (Fig. 2), and their migrations
were consistent with their slightly increased molecular mass
(39 213 and 38 881 respectively). Mass spectrometry analysis
of N-terminal His-tagged MurG was in agreement with its
theoretical mass (data not shown). The ¢nal products stored
at 320‡C remained soluble upon thawing.
The N-acetylglucosamine transferase activity of the three
MurG proteins was determined according to the previously
described assay [4] involving a coupling with the prior in
situ formation of lipid I catalyzed by the MraY transferase.
Values were 0.32, 1.1 and 2.2 nmol/min/mg for wild-type, N-
terminal His-tagged and C-terminal His-tagged MurG pro-
teins, respectively. Interestingly, if speci¢c activities are based
on the MurG protein contents estimated by SDS-PAGE the
value for the wild-type protein is in the range of the two other
ones (1.6, 1.4, and 2.8 nmol/min/mg, respectively). Moreover,
they were inhibited to the same extent (70^80%) by 50 Wg/ml
ramoplanin, thereby con¢rming the mechanism of action of
this lipoglycopeptide antibiotic whose target has been shown
to be the conversion of lipid I into lipid II in cell-free systems
from Bacillus megaterium and Ga¡kya homari [18].
4. Discussion
E. coli MurG appears to be a peripheral membrane protein
according to a number of criteria: partial solubilization by
salt treatments, puri¢cation without detergent, localization
on the inner side of the cytoplasmic membrane [9], a cationic
theoretical pI value of 9.7 and a lack of signi¢cant hydro-
phobic regions in its amino acid sequence [6,7]. A MurG
activity has been puri¢ed from B. megaterium after solubiliza-
tion by LiCl [17,19]. Moreover, the extrinsic character of
MurG appears to be a general feature as far as can be judged
from the 13 ortholog sequences currently accessible in data
banks. Interestingly, they all possess a speci¢c consensus se-
quence (GGTGGHXXPXXA/S) near their N-terminus.
The values of the speci¢c N-acetylglucosamine transferase
activity of the three puri¢ed MurG proteins are very low and
lead to a turnover of ca. 0.1/min, very far from the in vivo
rate (50 000^100 000 units per min per cell) in growing cells [2]
possessing presumably at most a few thousand MurG copies
per cell. This is probably not due to an inactivation of the
MurG transferases, since their speci¢c activities based on
MurG protein contents are similar, but rather to the condi-
tions of the assay itself. The de novo formed lipid I is in
limited amounts (reversibility of the MraY reaction and low
pool of undecaprenyl phosphate) and located in membrane
sites not easily accessible to tested soluble MurG. In vivo
MurG more probably functions in a very organized environ-
ment where lipids I and II are associated with membrane-
Fig. 2. Comparison of puri¢ed wild-type and His-tagged MurG pro-
teins by SDS-PAGE. Lane A, MurG (upper band) from
JM109(pDMC1); lane B, N-terminal His-tagged MurG from
JM109(pDMC2); lane C, C-terminal His-tagged MurG from
JM109(pDMC3); lane D, molecular mass standards as in Fig. 1.
SDS-PAGE conditions, standards and staining are as in Fig. 1.
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bound MraY and MurG, and where the e⁄ciency of the sys-
tem relies in some way on the coupling between the two trans-
ferase activities [2]. There is also a possible coupling with the
transport of lipid II through the membrane and its use in the
polymerization reactions. Recently, the associated MurG and
MraY transferases have been considered essential parts of the
divisome [20].
Attempts to develop an e⁄cient one-step MurG enzymatic
assay using directly lipid I have unfortunately been hampered
by the di⁄culty in obtaining large amounts of this intermedi-
ate [16,19,21]. Recently, direct assays have been developed
using synthetic analogs of lipid I with C10 or C35 lipid chains
[22,23]. Undoubtedly, the availability of reasonable amounts
of such substrates will greatly facilitate further detailed studies
of the MurG activity.
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